22nd Century Group, Inc.

NasdaqCM:XXII Stock Report

Market Cap: US$4.6m

22nd Century Group Past Earnings Performance

Past criteria checks 0/6

22nd Century Group's earnings have been declining at an average annual rate of -19.7%, while the Tobacco industry saw earnings growing at 9.6% annually. Revenues have been declining at an average rate of 4.2% per year.

Key information

-19.7%

Earnings growth rate

8.7%

EPS growth rate

Tobacco Industry Growth18.1%
Revenue growth rate-4.2%
Return on equity-959.6%
Net Margin-289.5%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Market Participants Recognise 22nd Century Group, Inc.'s (NASDAQ:XXII) Revenues Pushing Shares 1,233% Higher

Apr 02
Market Participants Recognise 22nd Century Group, Inc.'s (NASDAQ:XXII) Revenues Pushing Shares 1,233% Higher

Time To Worry? Analysts Just Downgraded Their 22nd Century Group, Inc. (NASDAQ:XXII) Outlook

Aug 20
Time To Worry? Analysts Just Downgraded Their 22nd Century Group, Inc. (NASDAQ:XXII) Outlook

With 22nd Century Group, Inc. (NASDAQ:XXII) It Looks Like You'll Get What You Pay For

Jun 14
With 22nd Century Group, Inc. (NASDAQ:XXII) It Looks Like You'll Get What You Pay For

Does 22nd Century Group (NASDAQ:XXII) Have A Healthy Balance Sheet?

Jan 13
Does 22nd Century Group (NASDAQ:XXII) Have A Healthy Balance Sheet?

22nd Century adds Creager as distribution partner for its VLN cigarettes in Colorado

Oct 03

Revenue & Expenses Breakdown

How 22nd Century Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:XXII Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2417-50121
30 Jun 2419-51172
31 Mar 2419-63242
31 Dec 2322-65313
30 Sep 2319-37281
30 Jun 2327-41362
31 Mar 2330-38353
31 Dec 2228-37324
30 Sep 2249-47395
30 Jun 2239-44315
31 Mar 2230-36284
31 Dec 2131-33264
30 Sep 2123-25234
30 Jun 2125-20194
31 Mar 2128-21174
31 Dec 2028-20154
30 Sep 2028-20134
30 Jun 2027-26146
31 Mar 2027-29137
31 Dec 1926-27138
30 Sep 1926-291110
30 Jun 1926-13912
31 Mar 1927-11915
31 Dec 1826-8915
30 Sep 1825-3913
30 Jun 1824-1299
31 Mar 1820-995
31 Dec 1717-1383
30 Sep 1714-1283
30 Jun 1713-1173
31 Mar 1711-1172
31 Dec 1612-1282
30 Sep 1612-1282
30 Jun 1611-1282
31 Mar 1611-1082
31 Dec 159-1192
30 Sep 156-14111
30 Jun 153-14121
31 Mar 151-14121
31 Dec 141-1691
30 Sep 148-1861
30 Jun 148-3041
31 Mar 148-2941
31 Dec 137-2641

Quality Earnings: XXII is currently unprofitable.

Growing Profit Margin: XXII is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: XXII is unprofitable, and losses have increased over the past 5 years at a rate of 19.7% per year.

Accelerating Growth: Unable to compare XXII's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: XXII is unprofitable, making it difficult to compare its past year earnings growth to the Tobacco industry (2.4%).


Return on Equity

High ROE: XXII has a negative Return on Equity (-959.56%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies